Pfizer to seek vaccine approval in November

Share

US pharmaceutical giant Pfizer Inc. said Friday that its application for emergency use authorization in the United States for its potential coronavirus vaccine will take place no earlier than the third week of November.

Pfizer's vaccine is one of the frontrunners among those being developed around the world. She said there are about 11 vaccines worldwide in late-stage testing, and another 200 candidates under development. "My administration will continue its collaboration with others as we build on our state's COVID response and plan for an eventual vaccine".

PFE, BNTX Price Action: At last check, Pfizer shares were gaining 2.5% to $37.46 and BioNTech shares were up 2.8% to $92.91. Second, and equally important, the vaccine must prove your safety, with robust safety data generated from thousands of patients.

To ensure public trust, Bourla explained the process and timeline that they are employing in making the vaccine. But the need for Bourla, who had previously said a vaccine could be available by October, to make a public announcement emphasizes the tense political conditions surrounding the race for a vaccine. However, this action will occur only if the safety and efficacy of the drug can be guaranteed created together with the BioNTech company. "As supplies of the vaccine rise, all Kentuckians are expected to have access", he said, adding that distributing the vaccine to as many as 4.4 million residents will likely take a year or more to complete.

"Each of the information in our USA program could be assessed not only by the FDA's scientists but also by an outside panel of independent experts at a publicly held assembly convened by the bureau".

However, at this time there is no set distribution date for a COVID-19 vaccine. No vaccine has been approved yet, and state officials say Maine's plan will evolve as more information is known.

Fauci wants Trump campaign to take down ad featuring him
In response to Fauci's allegations, a spokesperson from Trump's campaign said, "These are Dr. Anthony Fauci speaks in Washington, DC, US June 30, 2020.

This comes as a blow to the U.S. President, Donald Trump, who promised voters that a vaccine could be ready before the election, which is in early November.

But scientists have cautioned that this is an unlikely scenario.

The next phase of distribution would include essential workers, those living in congregate living settings, such as homeless shelters, group homes and college dorms, and others who are deemed more at-risk from coronavirus, such as adults 65 and older or adults with chronic health issues.

It has forecast that 35 million to 45 million doses of vaccines will be available in the United States by the end of this year from the first two companies to receive authorization. Recognizing the likelihood of limited availability, Nevada's plan first focuses on reducing the stress on the state's health care systems by prioritizing vulnerable populations and health care workers.

Gov. Doug Burgum, in conjunction with the North Dakota Department of Health (NDDoH), announced today that North Dakota has submitted its COVID-19 vaccination plan to the Centers for Disease Control and Prevention (CDC).

Share